Accepted at 8:50 p.m. Oct, 31, 2023 by Alex
Author: pfcarroll
Related Note: 1477089795846
Rationale for change

Integration with AMBOSS

Text Text
Extra
Tetrabenazine also inhibits VMAT (both may be used to treat Huntington disease)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Indirect Sympathomimetics
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::15_Tetrabenazine #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::02_Movement_Disorders #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::02_Indirect_Sympathomimetics #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::10_Sympathomimetics::Indirect !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#B&B::15_Neuro::07_Other::08_Parkinsons,_Huntingtons,_&_Movement_Disorders #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::13_Tetrabenazine #AK_Step1_v12::#OME::PreClinical::Biochemistry #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::10_Sympathomimetics::Indirect::Reserpine